Alternative Delivery of Dose Adjustment For Normal Eating (DAFNE) Trial in Patients With Type 1 Diabetes
Improving Management of Type 1 Diabetes in the UK: The DAFNE Programme as a Research Test-bed - 5 x 1 Day RCT
1 other identifier
interventional
170
1 country
7
Brief Summary
The best format for the delivery of structured education for adults with Type 1 diabetes is unclear. Currently some hospitals invite their patients to attend a 5 day outpatient course run over one week (Dose Adjustment For Normal Eating (DAFNE)). Other centres offer 1 day a week for 3 to 5 weeks. We aim to find out whether or not the benefit of benefits are the same then it would mean that the course could routinely be offered to patients in either format, thus allowing more patient choice and flexibility.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2010
Typical duration for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2010
CompletedFirst Posted
Study publicly available on registry
February 17, 2010
CompletedStudy Start
First participant enrolled
June 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedNovember 19, 2014
November 1, 2014
2 years
February 10, 2010
November 18, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Improvement in HbA1c (glycosylated haemoglobin)
6 & 12 months
Secondary Outcomes (3)
Number of severe hypoglycaemic episodes
12 months
Psychosocial measures, such as quality of life, emotional well-being, self-efficacy,will be assessed via questionnaires
12 months
Qualitative evaluation via in-depth interviews to assess patients' experiences of the intervention
12 months
Study Arms (2)
Standard DAFNE
ACTIVE COMPARATORUsual DAFNE course taught over 5 consecutive days in one week
DAFNE 5x1 day
EXPERIMENTALDAFNE course taught 1 day a week for 5 consecutive weeks
Interventions
Education delivered over one day a week for 5 consecutive weeks, as opposed to 5 consecutive days over 1 week.
Eligibility Criteria
You may qualify if:
- adults with Type 1 diabetes for at least 6 months
- HbA1c \<12%
- willing to undertake intensive insulin therapy
You may not qualify if:
- severe diabetic complications (making group education difficult)
- inability to communicate in English
- strong preference for on attending a one week course or one day a week for 5 consecutive weeks
- inability to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sheffield Teaching Hospitals NHS Foundation Trustlead
- University Hospitals, Leicestercollaborator
- Cambridge University Hospitals NHS Foundation Trustcollaborator
- University College London Hospitalscollaborator
- Northumbria Healthcare NHS Foundation Trustcollaborator
- NHS Greater Glasgow and Clydecollaborator
- Norfolk and Norwich University Hospitals NHS Foundation Trustcollaborator
- East Lancashire Hospitals NHS Trustcollaborator
Study Sites (7)
Cambridge University Hospitals NHS Foundation Trust
Cambridge, United Kingdom
NHS Greater Glasgow & Clyde
Glasgow, United Kingdom
East Lancashire Hospitals NHS Trust
Lancashire, United Kingdom
University Hospitals, Leicester
Leicester, United Kingdom
University College London
London, United Kingdom
Norfolk and Norwich University Hospitals NHS Foundation Trust
Norfolk, United Kingdom
Northumbria Healthcare NHS Foundation Trust
Northumbria, United Kingdom
Related Publications (1)
Elliott J, Lawton J, Rankin D, Emery C, Campbell M, Dixon S, Heller S; NIHR DAFNE Research Study Group. The 5x1 DAFNE study protocol: a cluster randomised trial comparing a standard 5 day DAFNE course delivered over 1 week against DAFNE training delivered over 1 day a week for 5 consecutive weeks. BMC Endocr Disord. 2012 Nov 8;12:28. doi: 10.1186/1472-6823-12-28.
PMID: 23136929DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Simon Heller, MD
Sheffield Teaching Hospitals NHS Foundation Trust
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2010
First Posted
February 17, 2010
Study Start
June 1, 2010
Primary Completion
June 1, 2012
Study Completion
June 1, 2012
Last Updated
November 19, 2014
Record last verified: 2014-11